FUS and amyotrophic lateral sclerosis: Moreover, upregulation of FUS wild-type protein expression due to mutations in its 3′ UTR regulatory region causes ALS in patients and ALS-like disease in animal models [17–20], further supporting a gain-of-function mechanism of neurotoxicity.